Headline Details

Drugmakers see a pricing blueprint in an $850,000 gene therapy

Published on: Fri, 12 Jan 2018 20:32:34 UTC
News Agency: Reuters
Description:
SAN FRANCISCO (Reuters) - Global drugmakers are looking to a tiny biotech's $850,000 therapy for a rare type of blindness as a model for getting paid for highly expensive – and effective – new medicines.

Click here for FULL Story on Reuters

Also happening now

HeadlineNews Agency
Trump invites Putin to Washington despite U.S. uproar over Helsinki summit Reuters
Brazil's 'Dr. Butt' plastic surgeon arrested after patient death: police Reuters
Turkish court rejects Australia's request to extradite Islamic State recruiter Reuters
The transgender acid attack survivor running for parliament BBC
Were occult practices behind India's 'house of mass hangings'? BBC